[Clinical trial of tibric acid, a new hypolipidemic agent].
D000328:Adult; D000368:Aged; D001565:Benzoates / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood*; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
D001565:Benzoates; D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010880:Piperidines; D013451:Sulfonic Acids; D014280:Triglycerides
Klinische Prüfung von "Tibric Acid", einem neuen lipidsenkenden Stoff